Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




AB Sciex

click to enlarge

Proteomics Analysis

Five new chips are available for the Eksigent line of column chips for the cHiPLC®-nanoflex system. The chips expand the application of the system for high-performance proteomics analysis including biomarker discovery, validation, and verification. The extended offering adds higher flow micro cHiPLC columns for peptide separation at increased throughput levels, as well as new phases for the analysis of intact proteins, phosphopeptides, and glycans. Two of the chips are nano LC columns—C4 for the analysis of intact proteins and graphitized carbon for phosphopeptides and glycans. The other new chips include the 200 µm i.d. C18-CL micro cHiPLC columns in 15 cm as well as a new shorter 5 cm length. These chips are run at 1.0 to 3.5 µL per-minute flow rates.

  • AB Sciex
  • 500 Old Connecticut Path
  • Framingham, MA, 01701
  • UNITED STATES

Related To This Company

Products

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll